| Code | 20654 | ||||||||||
| MA number | 20/0435/10-S | ||||||||||
| Product Form: | sol ijf 5x4 ml/8 mg (amp.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.06.2010 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ondansetron Accord 2 mg_ml injekčný alebo infúzny roztok_01_2020.doc
|
| PIL: |
PIL_Ondansetron Accord 2 mg_ml injekčný alebo infúzny roztok_04_2022.pdf
|
| Safety feature | Yes |
| Data update: | 13.03.2018 |
